Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062986) titled 'A Study of Trastuzumab Deruxtecan-Associated Interstitial Lung Disease Using Bronchoalveolar Lavage Fluid, Blood, and Other Clinical Samples' on Nov. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Gunma University Graduate School of Medicine
Condition:
Condition - Trastuzumab deruxtecan (T-DXd)-associated interstitial lung disease/pneumonitis
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Conducting integrative analyses ...